marketbeat.com

Stacey Associates buys Gilead shares; other funds add stakes, insider sells

Gilead Sciences logoGilead Sciences
Sig1.22Sen-0.78Env0.00Soc0.00Gov-0.27

Stacey Associates acquired 102,562 shares of Gilead Sciences for about $12.96 million, and other investors added smaller positions, including a new stake for Kimelman & Baird and additional purchases by Vermillion & White. An insider, Johanna Mercier, sold 28,000 shares for $2.68 million. Analysts’ targets were adjusted, with Barclays lowering its target and Royal Bank of Canada raising its.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro